Adrian Franke to Prognosis
This is a "connection" page, showing publications Adrian Franke has written about Prognosis.
Connection Strength
0.169
-
Wu AH, Franke AA, Wilkens LR, Tseng C, Conroy SM, Li Y, Sangaramoorthy M, Polfus LM, DeRouen MC, Caberto C, Haiman C, Stram DO, Le Marchand L, Cheng I. Risk of breast cancer and prediagnostic urinary excretion of bisphenol A, triclosan and parabens: The Multiethnic Cohort Study. Int J Cancer. 2021 10 01; 149(7):1426-1434.
Score: 0.041
-
Shidal C, Yoon HS, Zheng W, Wu J, Franke AA, Blot WJ, Shu XO, Cai Q. Prospective study of plasma levels of coenzyme Q10 and lung cancer risk in a low-income population in the Southeastern United States. Cancer Med. 2021 02; 10(4):1439-1447.
Score: 0.040
-
St John JA, Henderson VW, Hodis HN, Kono N, McCleary CA, Franke AA, Mack WJ. Associations between urine excretion of isoflavonoids and cognition in postmenopausal women in the Women's Isoflavone Soy Health clinical trial. J Am Geriatr Soc. 2014 Apr; 62(4):629-35.
Score: 0.025
-
Conroy SM, Maskarinec G, Morimoto Y, Franke AA, Cooney RV, Wilkens LR, Goodman MT, Hernadez BY, Le Marchand L, Henderson BE, Kolonel LN. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2013 Mar; 22(3):337-47.
Score: 0.023
-
Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, Franke AA, Bosland MC, Wang J, Hansen NM, Bethke KP, Dew A, Coomes M, Bergan RC. Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev Res (Phila). 2012 Feb; 5(2):309-19.
Score: 0.021
-
Cooney RV, Dai Q, Gao YT, Chow WH, Franke AA, Shu XO, Li H, Ji B, Cai Q, Chai W, Zheng W. Low plasma coenzyme Q(10) levels and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev. 2011 Jun; 20(6):1124-30.
Score: 0.020